Xenon Pharmaceuticals

XENE

Börsenwert 3,98 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 BVF Inc San Francisco, California	23,4 Mio. $	-522.792 $	-65.100	-2 %
2	2 Capital World Investors Los Angeles, California	9,43 Mio. $	+1,57 Mio. $	+195.000	+19 %
3	3 OrbiMed New York	7,7 Mio. $	–	–	–
4	4 Perceptive Advisors New York	5,7 Mio. $	-180.913 $	-22.528	-3 %
5	5 Tekla Capital Management Boston, Massachusetts	5,39 Mio. $	–	–	–
6	6 DAFNA Capital Management Los Angeles, California	3,96 Mio. $	–	–	–
7	OM 7 Opaleye Management Boston, Massachusetts	3,12 Mio. $	-40.153 $	-5.000	-1 %
8	8 Invesco Private Capital New York	3,08 Mio. $	-94.777 $	-11.802	-3 %
9	9 Sphera Funds Management Tel Aviv, Israel	2,53 Mio. $	+803.060 $	+100.000	+44 %
10	GTC 10 Ghost Tree Capital New York	2,5 Mio. $	–	–	–
11	11 InterWest Venture Management San Francisco, California	2,46 Mio. $	+2,57 Mio. $	+320.061	Neu
12	12 Point72 Asset Management Stamford, Connecticut	2,39 Mio. $	-388.296 $	-48.352	-13 %
13	13 Royal Bank of Canada Toronto, Ontario, Canada	1,9 Mio. $	-971.976 $	-121.034	-33 %
14	14 Millennium Management New York	1,49 Mio. $	+1,56 Mio. $	+193.674	Neu
15	15 Novo Holdings A/S Hellerup, Denmark	982.000 $	–	–	–
16	16 Renaissance Technologies New York	879.000 $	+144.551 $	+18.000	+19 %
17	17 Highland Capital Management (Texas) Dallas, Texas	848.000 $	-1,12 Mio. $	-139.787	-56 %
18	18 Essex Investment Management Boston, Massachusetts	540.000 $	+563.523 $	+70.172	Neu
19	19 State of New Jersey Common Pension Fund D Trenton, New Jersey	501.000 $	–	–	–
20	KPF 20 K2 Principal Fund Toronto, Ontario, Canada	441.000 $	+339.116 $	+42.228	+282 %
21	21 California Public Employees Retirement System Sacramento, California	424.000 $	+441.683 $	+55.000	Neu
22	22 Prelude Capital Management New York	269.000 $	+280.493 $	+34.928	Neu
23	23 Weiss Multi-Strategy Advisers New York	243.000 $	–	–	–
24	24 Scotia Capital Toronto, Ontario, Canada	160.000 $	-16 $	-2	-0 %
25	25 NJ State Employees Deferred Compensation Plan Trenton, New Jersey	154.000 $	–	–	–

Xenon Pharmaceuticals XENE Börsenwert 3,98 Mrd. $

Xenon Pharmaceuticals

XENE

Börsenwert 3,98 Mrd. $